Er Therapeutics Incの収益品質スコアはB+/47.392197です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Er Therapeutics Incはいつ収益を報告しますか?
Er Therapeutics Incの次の収益報告はに予定されています
Er Therapeutics Incの予想収益はいくらですか?
ウォール街のアナリストによると、Er Therapeutics Incの予想収益は$です。
Er Therapeutics Incは収益予想を上回りましたか?
Er Therapeutics Incの最近の収益は$で、予想を。
主要データ
前終値
$0.0001
始値
$0.0001
当日レンジ
$0.0001 - $0.0001
52週レンジ
$0.0001 - $0.0025
取引高
1.0K
平均取引高
111
配当利回り
--
1株当たり利益(TTM)
-0.00
時価総額
$5.8K
PNGMとは何ですか?
Pengram Corp. is an advanced gold exploration company. The company is headquartered in Bellingham, Washington and currently employs 0 full-time employees. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.